305
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Meta-analysis of doripenem vs comparators in patients with pseudomonas infections enrolled in four phase III efficacy and safety clinical trials

, , , &
Pages 3029-3036 | Accepted 08 Oct 2009, Published online: 23 Oct 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

David P. Nicolau, George Dimopoulos, Tobias Welte & Charles-Edouard Luyt. (2016) Can we improve clinical outcomes in patients with pneumonia treated with antibiotics in the intensive care unit?. Expert Review of Respiratory Medicine 10:8, pages 907-918.
Read now

Articles from other publishers (6)

So Won KimSangmin ChoeDong Jin KimDae Young ZangDong-Hwan Lee. (2018) Pharmacokinetics of Doripenem in Healthy Koreans and Monte Carlo Simulations to Explore Optimal Dosage Regimens in Patients With Normal and Enhanced Renal Function. Therapeutic Drug Monitoring 40:4, pages 425-434.
Crossref
Matteo Bassetti, Charles-Edouard Luyt, David P. Nicolau & Jérôme Pugin. (2016) Characteristics of an ideal nebulized antibiotic for the treatment of pneumonia in the intubated patient. Annals of Intensive Care 6:1.
Crossref
Matteo Bassetti, Tobias Welte & Richard G. Wunderink. (2016) Treatment of Gram-negative pneumonia in the critical care setting: is the beta-lactam antibiotic backbone broken beyond repair?. Critical Care 20:1.
Crossref
Xiao-Yu Qu, Ting-Ting Hu & Wei Zhou. (2015) A meta-analysis of efficacy and safety of doripenem for treating bacterial infections. The Brazilian Journal of Infectious Diseases 19:2, pages 156-162.
Crossref
Alimuddin Zumla, Ziad A Memish, Markus Maeurer, Matthew Bates, Peter Mwaba, Jaffar A Al-Tawfiq, David W Denning, Frederick G Hayden & David S Hui. (2014) Emerging novel and antimicrobial-resistant respiratory tract infections: new drug development and therapeutic options. The Lancet Infectious Diseases 14:11, pages 1136-1149.
Crossref
. (2010) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 19:7.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.